Department of Medicine.
Center for Digital Health Innovation, University of California, San Francisco, San Francisco, California, USA.
Curr Opin Endocrinol Diabetes Obes. 2021 Feb 1;28(1):21-29. doi: 10.1097/MED.0000000000000600.
The role of telehealth in the care of people with type 1 diabetes (T1D) has expanded dramatically during the coronavirus pandemic, and is expected to remain a major care delivery modality going forward. This review explores the landscape of recent evidence for telehealth in T1D care.
Telemedicine for routine T1D care has shown equivalence to standard in-person care, with respect to glycemic control, while also increasing access, convenience, and satisfaction. Telehealth use promotes increased engagement of adolescents with T1D. Telehealth platforms have successfully been used in the care of microvascular complications and to support mental health related to diabetes. Machine learning and advanced decision support will increasingly be used to augment T1D care, as recent evidence suggests increasing capabilities to improve glycemic control. A spectrum of digital connected care services are emerging to support people with diabetes with daily management of diabetes. Finally, policy and systems are required that promote data interoperability, telemedicine provision, and reimbursement to support the ongoing growth of telehealth in T1D.
A developing field of evidence supports use of telehealth in T1D. As this care modality scales, it has the potential to increase access to high-quality diabetes care for many people with T1D.
在冠状病毒大流行期间，远程医疗在 1 型糖尿病（T1D）患者护理中的作用显著扩大，预计未来仍将是主要的护理提供方式。这篇综述探讨了 T1D 护理中远程医疗的最新证据现状。
常规 T1D 护理的远程医疗在血糖控制方面与标准的面对面护理等效，同时还增加了可及性、便利性和满意度。远程医疗的使用促进了青少年 T1D 患者的参与度。远程医疗平台已成功用于微血管并发症的护理，并支持与糖尿病相关的心理健康。机器学习和先进的决策支持将越来越多地用于增强 T1D 的护理，因为最近的证据表明其具有提高血糖控制能力的潜力。一系列数字化互联护理服务正在涌现，以帮助糖尿病患者日常管理糖尿病。最后，需要政策和系统来促进数据互操作性、远程医疗服务的提供和报销，以支持远程医疗在 T1D 中的持续增长。
越来越多的证据支持远程医疗在 T1D 中的应用。随着这种护理模式的扩展，它有可能为许多 T1D 患者增加获得高质量糖尿病护理的机会。
